Key result
Valve-sparing root replacement cuts endocarditis risk ~87% vs. aortic root replacement.
Why the study?
Previous meta-analyses suggested an advantage with aortic valve-sparing interventions, but findings needed updating and extending to patients with other connective tissue disorders.
Does valve-sparing root replacement reduce complications compared to aortic root replacement in patients with Marfan syndrome and other connective tissue disorders with aortic aneurysm or dissection?
Meta-Analysis (n=4,025)
Does valve-sparing root replacement reduce complications compared to aortic root replacement in patients with Marfan syndrome and other connective tissue disorders with aortic aneurysm or dissection?
In patients with Marfan syndrome and related connective tissue disorders, valve-sparing root replacement reduces the risk of endocarditis but is associated with a higher risk of future valve reoperation compared to aortic root replacement.
Answers are grounded in this paper and cite their sources.
May favor valve-sparing to reduce endocarditis in connective tissue disorders; leaves open durability versus reoperation pending randomized trials.
BACKGROUND: Aortic aneurysm and dissection are important causes of morbimortality in patients with Marfan syndrome (MFS) and other connective tissue diseases that affect the cardiovascular tissues. Timely intervention through different surgical techniques improves the prognosis. Both sparing and replacement-type interventions of the aortic valve are used, but selection depends on the condition of the patient at the time of diagnosis, the patient's emergency condition, surgeon preference and hospital resources. Previous meta-analyses have suggested an advantage with the use of sparing-type interventions, but this finding must be updated and extended to patients with other connective tissue disorders. The objetive of this study is to evaluate the outcomes of valve-sparing root replacement versus aortic root replacement procedures in patients with MFS and similar connective tissue diseases that present with aortic aneurysm or dissection. METHODS: A systematic review of cohort studies that evaluated sparing-type (preserving, remodeling, reimplantation, Yacoub, David or Florida Sleeve) or replacement-type (repair, Bentall, Button-Bentall, composite valve graft or Cabrol) procedures in patients with Marfan, Loeys-Dietz, Beals-Hecht or Ehlers-Danlos syndromes was done. Studies were retrieved from the SCOPUS, MEDLINE, CINAHL, EMBASE and LILACS electronic databases up to January 2020 without language restrictions. Only studies that directly compared sparing- versus replacement-type procedures were included in the meta-analysis. RESULTS: A total of 33 studies (n=1,807 subjects) reported sparing-type surgical interventions and 26 studies (n=2,218 subjects) reported replacement-type surgical interventions. Pooled rates of endocarditis, thromboembolism and aneurysm were higher in replacement-type surgical intervention studies. Sixteen studies were included in the meta-analysis. Sparing-type interventions were associated with a reduced risk of endocarditis (RR =0.13, 95% CI: 0.03-0.61); however, replacement-type interventions favored freedom from valve reoperation (RR =2.39, 95% CI: 1.24-4.60). All studies were at low risk of bias. CONCLUSIONS: The choice of the best surgical technique is dependent on the type of disease (MFS or other connective tissue diseases) as well as the accompanying aortic and cardiovascular damage, since these key factors are heterogeneous. Although the results of this meta-analysis tend to show some advantages for one type of surgical intervention over the other and viceversa, the surgeon can only make the best decision during the surgical act.
No takes yet. Share an insight, caveat, or question.
Soto et al. (2021) conducted a meta-analysis in Marfan syndrome and other genetic connective tissue disorders with aortic aneurysm or dissection (n=4,025). Valve-sparing root replacement vs. Aortic root replacement was evaluated on Endocarditis (RR 0.13, 95% CI 0.03-0.61). Valve-sparing root replacement significantly reduced the risk of endocarditis (RR 0.13) compared to aortic root replacement, although replacement procedures favored freedom from valve reoperation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: